{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["PEG400", "baicalin", "cellular pharmacokinetics", "transporters", "vesicles"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38931853", "DateRevised": {"Year": "2024", "Month": "06", "Day": "29"}, "Article": {"Language": ["eng"], "ELocationID": ["731", "10.3390/pharmaceutics16060731"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "29"}], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "16", "Issue": "6", "PubDate": {"Year": "2024", "Month": "May", "Day": "29"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "Study on the Effect of Pharmaceutical Excipient PEG400 on the Pharmacokinetics of Baicalin in Cells Based on MRP2, MRP3, and BCRP Efflux Transporters.", "Abstract": {"AbstractText": ["Pharmaceutical excipient PEG400 is a common component of traditional Chinese medicine compound preparations. Studies have demonstrated that pharmaceutical excipients can directly or indirectly influence the disposition process of active drugs in vivo, thereby affecting the bioavailability of drugs. In order to reveal the pharmacokinetic effect of PEG400 on baicalin in hepatocytes and its mechanism, the present study first started with the effect of PEG400 on the metabolic disposition of baicalin at the hepatocyte level, and then the effect of PEG400 on the protein expression of baicalin-related transporters (BCRP, MRP2, and MRP3) was investigated by using western blot; the effect of MDCKII-BCRP, MDCKII-BCRP, MRP2, and MRP3 was investigated by using MDCKII-BCRP, MDCKII-MRP2, and MDCKII-MRP3 cell monolayer models, and membrane vesicles overexpressing specific transporter proteins (BCRP, MRP2, and MRP3), combined with the exocytosis of transporter-specific inhibitors, were used to study the effects of PEG400 on the transporters in order to explore the possible mechanisms of its action. The results demonstrated that PEG400 significantly influenced the concentration of baicalin in hepatocytes, and the AUC<sub>0-t</sub> of baicalin increased from 75.96 \u00b1 2.57 \u03bcg\u00b7h/mL to 106.94 \u00b1 2.22 \u03bcg\u00b7h/mL, 111.97 \u00b1 3.98 \u03bcg\u00b7h/mL, and 130.42 \u00b1 5.26 \u03bcg\u00b7h/mL (<i>p</i> \u02c2 0.05). Furthermore, the efflux rate of baicalin was significantly reduced in the vesicular transport assay and the MDCKII cell model transport assay, which indicated that PEG400 had a significant inhibitory effect on the corresponding transporters. In conclusion, PEG400 can improve the bioavailability of baicalin to some extent by affecting the efflux transporters and thus the metabolic disposition of baicalin in the liver."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmacy, Guizhou Medical University, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "Center of Microbiology and Biochemical Pharmaceutical Engineering, Department of Education of Guizhou, Guiyang 550025, China."}], "LastName": "Yang", "ForeName": "Dan", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmacy, Guizhou Medical University, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "Center of Microbiology and Biochemical Pharmaceutical Engineering, Department of Education of Guizhou, Guiyang 550025, China."}], "LastName": "Zhang", "ForeName": "Min", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmacy, Guizhou Medical University, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "Center of Microbiology and Biochemical Pharmaceutical Engineering, Department of Education of Guizhou, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China."}], "LastName": "Zhao", "ForeName": "Mei", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmacy, Guizhou Medical University, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "Center of Microbiology and Biochemical Pharmaceutical Engineering, Department of Education of Guizhou, Guiyang 550025, China."}], "LastName": "Li", "ForeName": "Chaoji", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmacy, Guizhou Medical University, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "Center of Microbiology and Biochemical Pharmaceutical Engineering, Department of Education of Guizhou, Guiyang 550025, China."}], "LastName": "Shang", "ForeName": "Leyuan", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Experimental Animal Center, Guizhou Medical University, Guiyang 550025, China."}], "LastName": "Zhang", "ForeName": "Shuo", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmacy, Guizhou Medical University, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "Center of Microbiology and Biochemical Pharmaceutical Engineering, Department of Education of Guizhou, Guiyang 550025, China."}], "LastName": "Wang", "ForeName": "Pengjiao", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmacy, Guizhou Medical University, Guiyang 550025, China."}, {"Identifier": [], "Affiliation": "Center of Microbiology and Biochemical Pharmaceutical Engineering, Department of Education of Guizhou, Guiyang 550025, China."}], "LastName": "Gao", "ForeName": "Xiuli", "Initials": "X"}], "GrantList": [{"GrantID": "82260810", "Agency": "The National Natural Science Foundation of China", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare that they have no known competing economic interests or personal relationships that could have appeared to influence the work reported in this article."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Giacomini K.M., Huang S.M., Tweedie D.J., Benet L.Z., Brouwer K.L., Chu X., Dahlin A., Evers R., Fischer V., Hillgren K.M., et al. Membrane transporters in drug development. Nat. Rev. Drug Discov. 2010;9:215\u2013236. doi: 10.1038/nrd3028.", "ArticleIdList": ["10.1038/nrd3028", "PMC3326076", "20190787"]}, {"Citation": "Hillgren K.M., Keppler D., Zur A.A., Giacomini K.M., Stieger B., Cass C.E., Zhang L. Emerging transporters of clinical importance: An update from the International Transporter Consortium. Clin. Pharmacol. Ther. 2013;94:52\u201363. doi: 10.1038/clpt.2013.74.", "ArticleIdList": ["10.1038/clpt.2013.74", "23588305"]}, {"Citation": "Chen T., Li Y., Li C., Yi X., Wang R., Lee S.M., Zheng Y. Pluronic P85/F68 Micelles of Baicalein Could Interfere with Mitochondria to Overcome MRP2-Mediated Efflux and Offer Improved Anti-Parkinsonian Activity. Mol. Pharm. 2017;14:3331\u20133342. doi: 10.1021/acs.molpharmaceut.7b00374.", "ArticleIdList": ["10.1021/acs.molpharmaceut.7b00374", "28806519"]}, {"Citation": "Ashiru D.A., Patel R., Basit A.W. Polyethylene glycol 400 enhances the bioavailability of a BCS class III drug (ranitidine) in male subjects but not females. Pharm. Res. 2008;25:2327\u20132333. doi: 10.1007/s11095-008-9635-y.", "ArticleIdList": ["10.1007/s11095-008-9635-y", "18600434"]}, {"Citation": "Suh M.G., Choi H.S., Cho K., Park S.S., Kim W.J., Suh H.J., Kim H. Anti-inflammatory action of herbal medicine comprised of Scutellaria baicalensis and Chrysanthemum morifolium. Biosci. Biotechnol. Biochem. 2020;84:1799\u20131809. doi: 10.1080/09168451.2020.1769464.", "ArticleIdList": ["10.1080/09168451.2020.1769464", "32448093"]}, {"Citation": "Zeng W., Cheng N.M., Liang X., Hu H., Luo F., Jin J., Li Y.W. Electrospun polycaprolactone nanofibrous membranes loaded with baicalin for antibacterial wound dressing. Sci. Rep. 2022;12:10900. doi: 10.1038/s41598-022-13141-0.", "ArticleIdList": ["10.1038/s41598-022-13141-0", "PMC9240071", "35764658"]}, {"Citation": "Xiang L., Gao Y., Chen S., Sun J., Wu J., Meng X. Therapeutic potential of Scutellaria baicalensis Georgi in lung cancer therapy. Phytomedicine. 2022;95:153727. doi: 10.1016/j.phymed.2021.153727.", "ArticleIdList": ["10.1016/j.phymed.2021.153727", "34535372"]}, {"Citation": "Cheng F., Lu Y., Zhong X., Song W., Wang X., Sun X., Qin J., Guo S., Wang Q. Baicalin\u2019s Therapeutic Time Window of Neuroprotection during Transient Focal Cerebral Ischemia and Its Antioxidative Effects In Vitro and In Vivo. Evid. Based Complement. Altern. Med. 2013;2013:120261. doi: 10.1155/2013/120261.", "ArticleIdList": ["10.1155/2013/120261", "PMC3708445", "23878589"]}, {"Citation": "Nigam S.K. What do drug transporters really do? Nat. Rev. Drug Discov. 2015;14:29\u201344. doi: 10.1038/nrd4461.", "ArticleIdList": ["10.1038/nrd4461", "PMC4750486", "25475361"]}, {"Citation": "Liu X. ABC Family Transporters. Adv. Exp. Med. Biol. 2019;1141:13\u2013100. doi: 10.1007/978-981-13-7647-4_2.", "ArticleIdList": ["10.1007/978-981-13-7647-4_2", "31571164"]}, {"Citation": "Jetter A., Kullak-Ublick G.A. Drugs and hepatic transporters: A review. Pharmacol. Res. 2020;154:104234. doi: 10.1016/j.phrs.2019.04.018.", "ArticleIdList": ["10.1016/j.phrs.2019.04.018", "31004787"]}, {"Citation": "Zhang L., Lin G., Kov\u00e1cs B., Jani M., Krajcsi P., Zuo Z. Mechanistic study on the intestinal absorption and disposition of baicalein. Eur. J. Pharm. Sci. 2007;31:221\u2013231. doi: 10.1016/j.ejps.2007.04.001.", "ArticleIdList": ["10.1016/j.ejps.2007.04.001", "17507208"]}, {"Citation": "Zhang L., Lin G., Zuo Z. Involvement of UDP-glucuronosyltransferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein. Pharm. Res. 2007;24:81\u201389. doi: 10.1007/s11095-006-9126-y.", "ArticleIdList": ["10.1007/s11095-006-9126-y", "17109214"]}, {"Citation": "Akao T., Hanada M., Sakashita Y., Sato K., Morita M., Imanaka T. Efflux of baicalin, a flavone glucuronide of Scutellariae Radix, on Caco-2 cells through multidrug resistance-associated protein 2. J. Pharm. Pharmacol. 2007;59:87\u201393. doi: 10.1211/jpp.59.1.0012.", "ArticleIdList": ["10.1211/jpp.59.1.0012", "17227625"]}, {"Citation": "Kalapos-Kov\u00e1cs B., Magda B., Jani M., Fekete Z., Szab\u00f3 P.T., Antal I., Krajcsi P., Klebovich I. Multiple ABC Transporters Efflux Baicalin. Phytother. Res. 2015;29:1987\u20131990. doi: 10.1002/ptr.5477.", "ArticleIdList": ["10.1002/ptr.5477", "26400418"]}, {"Citation": "Huang T., Liu Y., Zhang C. Pharmacokinetics and Bioavailability Enhancement of Baicalin: A Review. Eur. J. Drug Metab. Pharmacokinet. 2019;44:159\u2013168. doi: 10.1007/s13318-018-0509-3.", "ArticleIdList": ["10.1007/s13318-018-0509-3", "30209794"]}, {"Citation": "Mai Y., Dou L., Murdan S., Basit A.W. An animal\u2019s sex influences the effects of the excipient PEG 400 on the intestinal P-gp protein and mRNA levels, which has implications for oral drug absorption. Eur. J. Pharm. Sci. 2018;120:53\u201360. doi: 10.1016/j.ejps.2018.04.021.", "ArticleIdList": ["10.1016/j.ejps.2018.04.021", "29678614"]}, {"Citation": "Li L., Yi T., Lam C.W. Inhibition of human efflux transporter ABCC2 (MRP2) by self-emulsifying drug delivery system: Influences of concentration and combination of excipients. J. Pharm. Pharm. Sci. 2014;17:447\u2013460. doi: 10.18433/J3VP5H.", "ArticleIdList": ["10.18433/J3VP5H", "25579428"]}, {"Citation": "Lv L., You Y., Liu Y., Yang Z. Advanced Research in Cellular Pharmacokinetics and its Cutting-edge Technologies. Curr. Pharm. Des. 2022;28:3095\u20133104. doi: 10.2174/1381612828666220907102606.", "ArticleIdList": ["10.2174/1381612828666220907102606", "36082865"]}, {"Citation": "DellaValle D.M., Vandenberg A., Glahn R.P. Seed coat removal improves iron bioavailability in cooked lentils: Studies using an in vitro digestion/Caco-2 cell culture model. J. Agric. Food Chem. 2013;61:8084\u20138089. doi: 10.1021/jf4022916.", "ArticleIdList": ["10.1021/jf4022916", "23915260"]}, {"Citation": "Zha W., Liang G., Xiao J., Studer E.J., Hylemon P.B., Pandak W.M., Jr., Wang G., Li X., Zhou H. Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages. PLoS ONE. 2010;5:e9069. doi: 10.1371/journal.pone.0009069.", "ArticleIdList": ["10.1371/journal.pone.0009069", "PMC2817721", "20161729"]}, {"Citation": "Liu W.Y., Zhang J.W., Yao X.Q., Jiang C., He J.C., Ni P., Liu J.L., Chen Q.Y., Li Q.R., Zang X.J., et al. Shenmai injection enhances the cytotoxicity of chemotherapeutic drugs against colorectal cancers via improving their subcellular distribution. Acta Pharmacol. Sin. 2017;38:264\u2013276. doi: 10.1038/aps.2016.99.", "ArticleIdList": ["10.1038/aps.2016.99", "PMC5309759", "27867186"]}, {"Citation": "Feng S.Q., Wang G.J., Zhang J.W., Xie Y., Sun R.B., Fei F., Huang J.Q., Wang Y., Aa J.Y., Zhou F. Combined treatment with apatinib and docetaxel in A549 xenograft mice and its cellular pharmacokinetic basis. Acta Pharmacol. Sin. 2018;39:1670\u20131680. doi: 10.1038/aps.2018.16.", "ArticleIdList": ["10.1038/aps.2018.16", "PMC6289402", "29770798"]}, {"Citation": "Zhou F., Hao G., Zhang J., Zheng Y., Wu X., Hao K., Niu F., Luo D., Sun Y., Wu L., et al. Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: A correlation with the inhibition of carbonyl reductase-mediated metabolism. Br. J. Pharmacol. 2015;172:5690\u20135703. doi: 10.1111/bph.12995.", "ArticleIdList": ["10.1111/bph.12995", "PMC4667859", "25363561"]}, {"Citation": "Zhou F., Zhang J., Li P., Niu F., Wu X., Wang G., Roberts M.S. Toward a new age of cellular pharmacokinetics in drug discovery. Drug Metab. Rev. 2011;43:335\u2013345. doi: 10.3109/03602532.2011.560607.", "ArticleIdList": ["10.3109/03602532.2011.560607", "21395404"]}, {"Citation": "Jiang H., Yu J., Zheng H., Chen J., Wu J., Qi X., Wang Y., Wang X., Hu M., Zhu L., et al. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Regulate the Disposition of Acacetin Glucuronides. Pharm. Res. 2017;34:1402\u20131415. doi: 10.1007/s11095-017-2157-8.", "ArticleIdList": ["10.1007/s11095-017-2157-8", "28421306"]}, {"Citation": "Li L., Yi T., Lam C.W. Interactions between human multidrug resistance related protein (MRP2; ABCC2) and excipients commonly used in self-emulsifying drug delivery systems (SEDDS) Int. J. Pharm. 2013;447:192\u2013198. doi: 10.1016/j.ijpharm.2013.02.016.", "ArticleIdList": ["10.1016/j.ijpharm.2013.02.016", "23462368"]}, {"Citation": "Sahi J., Grepper S., Smith C. Hepatocytes as a tool in drug metabolism, transport and safety evaluations in drug discovery. Curr. Drug Discov. Technol. 2010;7:188\u2013198. doi: 10.2174/157016310793180576.", "ArticleIdList": ["10.2174/157016310793180576", "20843293"]}, {"Citation": "Evers R., Kool M., Smith A.J., van Deemter L., de Haas M., Borst P. Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport. Br. J. Cancer. 2000;83:366\u2013374. doi: 10.1054/bjoc.2000.1260.", "ArticleIdList": ["10.1054/bjoc.2000.1260", "PMC2374556", "10917553"]}, {"Citation": "Glavinas H., M\u00e9hn D., Jani M., Oosterhuis B., Her\u00e9di-Szab\u00f3 K., Krajcsi P. Utilization of membrane vesicle preparations to study drug-ABC transporter interactions. Expert Opin. Drug Metab. Toxicol. 2008;4:721\u2013732. doi: 10.1517/17425255.4.6.721.", "ArticleIdList": ["10.1517/17425255.4.6.721", "18611113"]}, {"Citation": "Pollard J., Rajabi-Siahboomi A., Badhan R.K.S., Mohammed A.R., Perrie Y. High-throughput screening of excipients with a biological effect: A kinetic study on the effects of surfactants on efflux-mediated transport. J. Pharm. Pharmacol. 2019;71:889\u2013897. doi: 10.1111/jphp.13072.", "ArticleIdList": ["10.1111/jphp.13072", "30784086"]}, {"Citation": "Kou L., Sun R., Bhutia Y.D., Yao Q., Chen R. Emerging advances in P-glycoprotein inhibitory nanomaterials for drug delivery. Expert Opin. Drug Deliv. 2018;15:869\u2013879. doi: 10.1080/17425247.2018.1517749.", "ArticleIdList": ["10.1080/17425247.2018.1517749", "30169976"]}, {"Citation": "Mai Y., Afonso-Pereira F., Murdan S., Basit A.W. Excipient-mediated alteration in drug bioavailability in the rat depends on the sex of the animal. Eur. J. Pharm. Sci. 2017;107:249\u2013255. doi: 10.1016/j.ejps.2017.07.009.", "ArticleIdList": ["10.1016/j.ejps.2017.07.009", "28709912"]}, {"Citation": "Lo Y.L. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. J. Control. Release. 2003;90:37\u201348. doi: 10.1016/s0168-3659(03)00163-9.", "ArticleIdList": ["10.1016/s0168-3659(03)00163-9", "12767705"]}, {"Citation": "Wei J., Liu R., Zhang J., Liu S., Yan D., Wen X., Tian X. Baicalin Enhanced Oral Bioavailability of Sorafenib in Rats by Inducing Intestine Absorption. Front. Pharmacol. 2021;12:761763. doi: 10.3389/fphar.2021.761763.", "ArticleIdList": ["10.3389/fphar.2021.761763", "PMC8606670", "34819863"]}, {"Citation": "Lee W.H., Loo C.Y., Young P.M., Traini D., Mason R.S., Rohanizadeh R. Recent advances in curcumin nanoformulation for cancer therapy. Expert Opin. Drug Deliv. 2014;11:1183\u20131201. doi: 10.1517/17425247.2014.916686.", "ArticleIdList": ["10.1517/17425247.2014.916686", "24857605"]}, {"Citation": "Yang K.Y., Lin L.C., Tseng T.Y., Wang S.C., Tsai T.H. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2007;853:183\u2013189. doi: 10.1016/j.jchromb.2007.03.010.", "ArticleIdList": ["10.1016/j.jchromb.2007.03.010", "17400527"]}, {"Citation": "Carcaboso A.M., Elmeliegy M.A., Shen J., Juel S.J., Zhang Z.M., Calabrese C., Tracey L., Waters C.M., Stewart C.F. Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas. Cancer Res. 2010;70:4499\u20134508. doi: 10.1158/0008-5472.Can-09-4264.", "ArticleIdList": ["10.1158/0008-5472.Can-09-4264", "PMC2880208", "20460504"]}, {"Citation": "Cao S., Zhang M., Yuan M., Yang D., Zhao M., Zhang S., Wang P., Zhang R., Gao X. The pharmaceutical excipient PEG400 affect the absorption of baicalein in Caco-2 monolayer model by interacting with UDP-glucuronosyltransferases and efflux transport proteins. Pharmacol. Res. Perspect. 2022;10:e00928. doi: 10.1002/prp2.928.", "ArticleIdList": ["10.1002/prp2.928", "PMC8929329", "35148019"]}, {"Citation": "Shang L.Y., Zhou M.H., Cao S.Y., Zhang M., Wang P.J., Zhang S., Meng X.X., Yang Q.M., Gao X.L. Effect of polyethylene glycol 400 on the pharmacokinetics and tissue distribution of baicalin by intravenous injection based on the enzyme activity of UGT1A8/1A9. Eur. J. Pharm. Sci. 2023;180:106328. doi: 10.1016/j.ejps.2022.106328.", "ArticleIdList": ["10.1016/j.ejps.2022.106328", "36379359"]}, {"Citation": "Shi X., Zhang G., Mackie B., Yang S., Wang J., Shan L. Comparison of the in vitro metabolism of psoralidin among different species and characterization of its inhibitory effect against UDP-glucuronosyltransferase (UGT) or cytochrome p450 (CYP450) enzymes. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2016;1029\u20131030:145\u2013156. doi: 10.1016/j.jchromb.2016.06.031.", "ArticleIdList": ["10.1016/j.jchromb.2016.06.031", "27428458"]}, {"Citation": "Zhao Q., Wei J., Zhang H. Effects of quercetin on the pharmacokinetics of losartan and its metabolite EXP3174 in rats. Xenobiotica. 2019;49:563\u2013568. doi: 10.1080/00498254.2018.1478168.", "ArticleIdList": ["10.1080/00498254.2018.1478168", "29768080"]}, {"Citation": "Xiao L., Yi T., Chen M., Lam C.W., Zhou H. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP. Eur. J. Pharm. Sci. 2016;93:456\u2013467. doi: 10.1016/j.ejps.2016.08.054.", "ArticleIdList": ["10.1016/j.ejps.2016.08.054", "27586020"]}, {"Citation": "Faber K.N., M\u00fcller M., Jansen P.L. Drug transport proteins in the liver. Adv. Drug Deliv. Rev. 2003;55:107\u2013124. doi: 10.1016/s0169-409x(02)00173-4.", "ArticleIdList": ["10.1016/s0169-409x(02)00173-4", "12535576"]}, {"Citation": "Bakos E., Evers R., Szak\u00e1cs G., Tusn\u00e1dy G.E., Welker E., Szab\u00f3 K., de Haas M., van Deemter L., Borst P., V\u00e1radi A., et al. Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain. J. Biol. Chem. 1998;273:32167\u201332175. doi: 10.1074/jbc.273.48.32167.", "ArticleIdList": ["10.1074/jbc.273.48.32167", "9822694"]}, {"Citation": "Borst P., Evers R., Kool M., Wijnholds J. A family of drug transporters: The multidrug resistance-associated proteins. J. Natl. Cancer Inst. 2000;92:1295\u20131302. doi: 10.1093/jnci/92.16.1295.", "ArticleIdList": ["10.1093/jnci/92.16.1295", "10944550"]}, {"Citation": "Kool M., van der Linden M., de Haas M., Scheffer G.L., de Vree J.M., Smith A.J., Jansen G., Peters G.J., Ponne N., Scheper R.J., et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. Proc. Natl. Acad. Sci. USA. 1999;96:6914\u20136919. doi: 10.1073/pnas.96.12.6914.", "ArticleIdList": ["10.1073/pnas.96.12.6914", "PMC22016", "10359813"]}, {"Citation": "Jonker J.W., Smit J.W., Brinkhuis R.F., Maliepaard M., Beijnen J.H., Schellens J.H., Schinkel A.H. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J. Natl. Cancer Inst. 2000;92:1651\u20131656. doi: 10.1093/jnci/92.20.1651.", "ArticleIdList": ["10.1093/jnci/92.20.1651", "11036110"]}, {"Citation": "Rege B.D., Kao J.P., Polli J.E. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur. J. Pharm. Sci. 2002;16:237\u2013246. doi: 10.1016/s0928-0987(02)00055-6.", "ArticleIdList": ["10.1016/s0928-0987(02)00055-6", "12208453"]}, {"Citation": "Sachs-Barrable K., Thamboo A., Lee S.D., Wasan K.M. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells. J. Pharm. Pharm. Sci. 2007;10:319\u2013331.", "ArticleIdList": ["17727795"]}, {"Citation": "Romsicki Y., Sharom F.J. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter. Biochemistry. 1999;38:6887\u20136896. doi: 10.1021/bi990064q.", "ArticleIdList": ["10.1021/bi990064q", "10346910"]}, {"Citation": "Shono Y., Nishihara H., Matsuda Y., Furukawa S., Okada N., Fujita T., Yamamoto A. Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes. J. Pharm. Sci. 2004;93:877\u2013885. doi: 10.1002/jps.20017.", "ArticleIdList": ["10.1002/jps.20017", "14999725"]}, {"Citation": "Dudeja P.K., Anderson K.M., Harris J.S., Buckingham L., Coon J.S. Reversal of multidrug resistance phenotype by surfactants: Relationship to membrane lipid fluidity. Arch. Biochem. Biophys. 1995;319:309\u2013315. doi: 10.1006/abbi.1995.1298.", "ArticleIdList": ["10.1006/abbi.1995.1298", "7771801"]}, {"Citation": "Hugger E.D., Novak B.L., Burton P.S., Audus K.L., Borchardt R.T. A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. J. Pharm. Sci. 2002;91:1991\u20132002. doi: 10.1002/jps.10176.", "ArticleIdList": ["10.1002/jps.10176", "12210046"]}, {"Citation": "Al-Shdefat R., Hailat M., Alshogran O.A.-O. Solubilization of a novel antitumor drug ribociclib in water and ten different organic solvents at different temperatures. Drug Dev. Ind. Pharm. 2022;48:12\u201320. doi: 10.1080/03639045.2022.2089161.", "ArticleIdList": ["10.1080/03639045.2022.2089161", "35695255"]}, {"Citation": "D\u2019Souza A.A., Shegokar R. Polyethylene glycol (PEG): A versatile polymer for pharmaceutical applications. Expert Opin. Drug Deliv. 2016;13:1257\u20131275. doi: 10.1080/17425247.2016.1182485.", "ArticleIdList": ["10.1080/17425247.2016.1182485", "27116988"]}]}], "History": [{"Year": "2024", "Month": "4", "Day": "22"}, {"Year": "2024", "Month": "5", "Day": "27"}, {"Year": "2024", "Month": "5", "Day": "27"}, {"Year": "2024", "Month": "6", "Day": "27", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "6", "Day": "27", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "6", "Day": "27", "Hour": "1", "Minute": "25"}, {"Year": "2024", "Month": "5", "Day": "29"}], "PublicationStatus": "epublish", "ArticleIdList": ["38931853", "PMC11206988", "10.3390/pharmaceutics16060731", "pharmaceutics16060731"]}}]}